- document
-
van den Akker-van Marle, M.E. (author), Gurwitz, D. (author), Detmar, S.B. (author), Enzing, C.M. (author), Hopkins, M.M. (author), Gutierrez De Mesa, E. (author), Ibarreta, D. (author), TNO Kwaliteit van Leven (author)Only a few studies have addressed the cost-effectiveness of pharmacogenetics interventions in healthcare. Lack of health economics data on aspects of pharmacogenetics is perceived as one of the barriers hindering its implementation for improving drug safety. Thus, a recent Institute for Prospective Technological Studies (IPTS) study, entitled ...article 2006
- document
-
van den Akker-van Marle, M.E. (author), Dankert, H.M. (author), Verkerk, P.H. (author), Dankert-Roelse, J.E. (author), TNO Kwaliteit van Leven (author)OBJECTIVES. The purpose of this work was to assess the costs of 4 neonatal screening strategies for cystic fibrosis in relation to health effects. In each strategy, the first test was the measurement of serum concentration of immunoreactive trypsin. The second step consisted of either a second immunoreactive trypsin test (strategy 1) or a...article 2006
- document
- TNO Kwaliteit van Leven (author), van den Akker-van Marle, M.E. (author), Rodrigues Pereira, R. (author), Verkerk, P.H. (author) report 2006
- document
-
TNO Kwaliteit van Leven (author), Enzing, C. (author), van den Akker-van Marle, M.E. (author), Detmar, S. (author), Vullings, W. (author), Hedgecoe, A. (author), Hopkins, M. (author), Ryan, J. (author), Forde, T. (author), Hartig, J. (author), Gaisser, S. (author)JPBreport 2006
- document
-
van den Akker-van Marle, M.E. (author), Rijnders, M.E.B. (author), van Dommelen, P. (author), Fekkes, M. (author), van Wouwe, J.P. (author), Amelink-Verburg, M.P. (author), Verkerk, P.H. (author)Objective: To estimate the costs and effects of different treatment strategies with intrapartum antibiotic prophylaxis to prevent early-onset group B streptococcal (GBS) disease in the Netherlands. The treatment strategies include a risk-based strategy, a screening-based strategy, a combined screening/risk-based strategy and the current Dutch...article 2005
- document
- van den Akker-van Marle, M.E. (author), Bruil, J. (author), Detmar, S.B. (author), TNO Kwaliteit van Leven (author) article 2005
- document
-
Bousquet, J. (author), Demarteau, N. (author), Mullol, J. (author), van den Akker-van Marle, M.E. (author), van Ganse, E. (author), Bachert, C. (author), TNO Preventie en Gezondheid (author)Background: Allergic rhinitis was recently classified by the ARIA guidelines as persistent or intermittent. Levocetivizine was shown to improve symptoms and health-related quality of life of patients with persistent allergic rhinitis in the XPERTâ„¢ study, a 6-month randomized double blind placebo-controlled trial. Objective: To assess the total...article 2005
- document
- TNO Preventie en Gezondheid (author), Verkerk, P.H. (author), Hirasing, R.A. (author), Rodrigues Pereira, R. (author), Ory, F.G. (author), Akker-van Marle. M.E. van den, (author) other 2004
- document
- TNO Preventie en Gezondheid (author), van den Akker-van Marle, M.E. (author) doctoral thesis 2003